Literature DB >> 23920442

Obesity and nosocomial infections.

R Huttunen1, M Karppelin, J Syrjänen.   

Abstract

BACKGROUND: The prevention of healthcare-associated infections (HCAIs) is a major goal in modern healthcare. Intrinsic, patient-related factors may contribute to the risk of HCAIs. AIM: To review the association between obesity and the risk and outcome of HCAIs.
METHODS: A PubMed search of relevant studies on obesity and nosocomial infections and obesity and dosing of antimicrobials. Search terms were: 'obesity', 'infection', 'nosocomial infection', 'surgical site infection', 'critical care unit', 'bacteremia', 'urinary tract infection', 'health care associated infection'.
FINDINGS: Obesity has been shown to be associated with an increased risk of HCAIs in several studies. The association is most clear in cardiac, vascular, orthopaedic and gastrointestinal surgery. Body mass index (BMI) data are frequently recorded in patients undergoing surgical and invasive procedures. The recording of BMI data is not systematic in the literature and in many studies median BMI of the control group or reference group (normal weight) also indicates overweight or obesity. Thus, clear BMI cut-offs for increased infection risk cannot be determined. Obesity is frequently associated with underdosing of antimicrobials in both prophylaxis and treatment of HCAIs. Studies indicate that obesity affects the pharmacokinetics of antimicrobial drugs. However, there are no dosing recommendations for antimicrobial use in obesity.
CONCLUSIONS: Obesity increases the risk of nosocomial infections and is frequently associated with underdosing of antimicrobials in both prophylaxis and treatment of HCAIs. A challenge in future hospital hygiene prevention lies in our capacity to combat obesity epidemics.
© 2013 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Epidemic; Nosocomial infection; Obesity; Risk; Surgical

Mesh:

Year:  2013        PMID: 23920442     DOI: 10.1016/j.jhin.2013.06.012

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  18 in total

1.  Information provision for antibacterial dosing in the obese patient: a sizeable absence?

Authors:  Sara Elizabeth Boyd; Esmita Charani; Tracy Lyons; Gary Frost; Alison Helen Holmes
Journal:  J Antimicrob Chemother       Date:  2016-08-18       Impact factor: 5.790

2.  Decreased Long-Term Respiratory Infection Risk After Bariatric Surgery: a Comprehensive National Cohort Study.

Authors:  Jian-Han Chen; Yu-Feng Wei; Chung-Yen Chen; Yu-Chieh Su; Robert Shan Fon Tsai; Wei-Leng Chin; Ho-Shen Lee
Journal:  Obes Surg       Date:  2020-09-28       Impact factor: 4.129

3.  Exercise Improves Host Response to Influenza Viral Infection in Obese and Non-Obese Mice through Different Mechanisms.

Authors:  Kristi J Warren; Molly M Olson; Nicholas J Thompson; Mackenzie L Cahill; Todd A Wyatt; Kyoungjin J Yoon; Christina M Loiacono; Marian L Kohut
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Nonpregnant Adults in the United States.

Authors:  Samantha I Pitts; Nisa M Maruthur; Gayle E Langley; Tracy Pondo; Kathleen A Shutt; Rosemary Hollick; Stephanie J Schrag; Ann Thomas; Megin Nichols; Monica Farley; James P Watt; Lisa Miller; William Schaffner; Corinne Holtzman; Lee H Harrison
Journal:  Open Forum Infect Dis       Date:  2018-06-08       Impact factor: 3.835

Review 5.  Coronavirus disease-2019: A tocsin to our aging, unfit, corpulent, and immunodeficient society.

Authors:  David C Nieman
Journal:  J Sport Health Sci       Date:  2020-05-08       Impact factor: 7.179

6.  AMPKα pathway involved in hepatic triglyceride metabolism disorder in diet-induced obesity mice following Escherichia coli Infection.

Authors:  Jing Fang; Fengyuan Wang; Hetao Song; Zhengyi Wang; Zhicai Zuo; Hengmin Cui; Yiping Jia; Junliang Deng; Shumin Yu; Yanchun Hu; Liuhong Shen; Xiaoping Ma; Zhihua Ren; Liping Gou
Journal:  Aging (Albany NY)       Date:  2018-11-06       Impact factor: 5.682

7.  Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.

Authors:  Philip A Giordano; Jason M Pogue; Sue Cammarata
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

8.  Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis.

Authors:  Vivek Singh Malik; Khaiwal Ravindra; Savita Verma Attri; Sanjay Kumar Bhadada; Meenu Singh
Journal:  Environ Sci Pollut Res Int       Date:  2020-07-24       Impact factor: 5.190

9.  Infection following penile prosthesis placement at an academic training center remains low despite involvement of surgeons-in-training.

Authors:  Kara E McAbee; Amy M Pearlman; Ryan P Terlecki
Journal:  Investig Clin Urol       Date:  2018-07-25

10.  Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections.

Authors:  Melissa Santibañez; Kristen Bunnell; Amanda Harrington; Susan Bleasdale; Eric Wenzler
Journal:  Open Forum Infect Dis       Date:  2019-09-19       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.